Clinical trial
Fibroblast Growth Factor 21 and Fructose Challenge in Humans
NCT02884791 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fibroblast Growth Factor 21 and Fructose Challenge in Humans
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- May 30, 2023
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fasting